Literature DB >> 31759773

Socioeconomic deprivation and survival in endometrial cancer: The effect of BMI.

H Donkers1, R Bekkers2, L Massuger3, K Galaal4.   

Abstract

OBJECTIVES:
METHODS: This is a retrospective study of surgically managed endometrial cancer patients in the Royal Cornwall Hospital Truro between January 2006 and August 2017. Patient characteristics, overall survival, recurrence free survival and intra- and postoperative outcomes were evaluated across socioeconomic deprivation groups in which socioeconomic deprivation was measured with the English Indices of Multiple Deprivation (IMD).
RESULTS: In total, we identified 831 women, of which 690 were included. The median age was 66 years with a median BMI of 31 and the majority of tumours were endometrioid tumours (80.1%). For type 1 (endometrioid) tumours, better survival was seen in the least deprived patients, however this was not significant in a multivariate analysis and only age, stage and BMI remained significant. For type 2 (all other) tumours, no association between survival and socioeconomic deprivation was found and only stage was significant. However, more affluent patients had significantly higher recurrence rates. In addition, we did not find evidence of an association between intra- or post-operative complication rates and socioeconomic deprivation.
CONCLUSION: Socioeconomic deprivation is associated with survival in endometrial cancer patients, however after adjusting for confounders this association does not remain. Only age, stage and BMI are independent prognostic factors for survival. In addition, there is no evidence of association between socioeconomic deprivation and peri-operative outcomes in endometrial cancer patients.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Body mass index; Deprivation; Gynaecological cancer; Perioperative morbidity; Socioeconomic status; Survival

Mesh:

Year:  2019        PMID: 31759773     DOI: 10.1016/j.ygyno.2019.10.030

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

Review 1.  Current and Emerging Prognostic Biomarkers in Endometrial Cancer.

Authors:  Kelechi Njoku; Chloe E Barr; Emma J Crosbie
Journal:  Front Oncol       Date:  2022-04-22       Impact factor: 5.738

2.  Impact of socio-economic deprivation on endometrial cancer survival in the North West of England: a prospective database analysis.

Authors:  K Njoku; C E Barr; L Hotchkies; N Quille; Y L Wan; E J Crosbie
Journal:  BJOG       Date:  2021-01-11       Impact factor: 6.531

3.  Clinicopathological Characteristics and Prognosis in Endometrial Cancer With Bone Metastasis: A SEER-Based Study of 584 Women.

Authors:  Hejia Hu; Zhan Wang; Miaofeng Zhang; Feng Niu; Qunfei Yu; Ying Ren; Zhaoming Ye
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

Review 4.  Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities.

Authors:  Rahaba Marima; Rodney Hull; Mandisa Mbeje; Thulo Molefi; Kgomotso Mathabe; Abdulrahman M Elbagory; Demetra Demetriou; Zodwa Dlamini
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

Review 5.  Endometrial cancer-is our knowledge changing?

Authors:  Milena Králíčková; Vaclav Vetvicka; Antonio Simone Laganà
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

6.  Socioeconomic disparities in endometrial cancer survival in Germany: a survival analysis using population-based cancer registry data.

Authors:  Ahmed Bedir; Semaw Ferede Abera; Dirk Vordermark; Daniel Medenwald
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-22       Impact factor: 4.322

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.